Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Topical finasteride helps regrow hair and reduce balding without side effects.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Dosing time affects finasteride's effectiveness and safety in rats.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

APKH in young males may signal early hair loss and needs early attention.

Meloside A may help protect hair cells from damage linked to hair loss.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.